Eurofins expands its offering in food testing with the acquisition of Institut Nehring

Eurofins Scientific (EUFI.PA), the world leader in food testing services announces that it has acquired Institut Nehring GmbH (“Institut Nehring”), a leading food testing laboratory in the German market.

Institut Nehring was established in 1905; today the company is well-known in the German market thanks to its long-history and excellent reputation. Institut Nehring performs a wide range of analytical tests for all food products, including: chemical, physical, biochemical, microbiological and sensorial testing. Additionally, these food testing services are accompanied by food consultancy services that cover food law, food technology, food safety and hygiene, food quality control, site inspections and audits, harm reports and expert counselling. To conclude this extensive food testing and services portfolio, Institut Nehring is a specialist in testing food contact materials especially canned food packaging. The company has a long-standing and broad customer base, including retailers, importers, wholesalers and producers of food products, as well as companies and regulatory bodies operating in the food packaging industry. The company is headquartered in Braunschweig, Germany, employs 76 staff and generates annual revenues close to EUR 5m.

The acquisition of Institut Nehring is an opportunity for Eurofins to further expand its market share in the German food testing market. The company’s broad expertise in food packaging testing will contribute to the expansion of Eurofins’ food testing portfolio, the most comprehensive range of state-of-the-art analytical food testing methods in the world.

Comment from Dr. Gilles Martin, Eurofins’ CEO: “We are pleased to welcome Institut Nehring, a highly renowned food testing laboratory with a long history, to Eurofins’ family of businesses. The acquisition of Institut Nehring will expand Eurofins’ food packaging material testing services. In return, Institut Nehring will gain access to the Group’s entire portfolio of competencies, logistics and clients, as well as the Group’s IT systems, which should lead to improved process optimization to the benefit of Institut Nehring’s customers. This transaction is another demonstration of Eurofins’ commitment to acquire advanced technologies to expand its state-of-the-art portfolio of analytical services.”

For more information, please visit www.eurofins.com or contact:

Notes for the editor:

Eurofins – a global leader in bio-analysis

Eurofins Scientific through its subsidiaries (hereinafter sometimes “Eurofins” or “the Group”) believes it is the world leader in food, environment and pharmaceutical products testing and that it is also one of the global independent market leaders in certain testing and laboratory services for agroscience, genomics, discovery pharmacology and for supporting clinical studies. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA. With over 30,000 staff in 375 laboratories across 41 countries, Eurofins offers a portfolio of over 130,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group objective is to provide its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.

As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.

The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).

Important disclaimer:

This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgment of Eurofins Scientific’s management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the information available to the Company’s management as of the date of publication, but no guarantee can be made as to their validity.